Dr. Julian J. Lum is an expert in the study of T cell metabolism and autophagy. His laboratory has a long-standing interest in delineating how metabolism impacts T cell immune responses. The lab employs a top-down approach whereby they study primary human biospecimens to further understand direct mechanisms of action using preclinical model systems. The primary goal of the Lum lab is to translate findings into interventions that can be applied in the context of cancer immunotherapies, with a focus on ovarian and prostate cancer.
Lum Lab
Members
Faculty/Leaders
![](/dept/drc/dept/drc/sites/deelyresearch/files/styles/profile/public/2019-10/Julian_Lum_crop.jpg?itok=FSmvdDkz)
Dr. Julian J. Lum, PhD
Distinguished Scientist
Staff
![](/dept/drc/sites/deelyresearch/files/styles/profile/public/2023-03/RyanGuagliano_profile%20%283%29.jpg?itok=mIelId5H)
Ryan Guagliano, BSc, BComm
Research Assistant II, Immunotherapy team
![](/dept/drc/sites/deelyresearch/files/styles/profile/public/2021-02/Elaine.jpg?itok=g-bTIDjv)
Elaine Liu, MSc
Casual Research Assistant II
![](/dept/drc/sites/deelyresearch/files/styles/profile/public/2021-02/Sarah.jpg?itok=vXiQmr7e)
Sarah MacPherson
Research Assistant III
![](/dept/drc/sites/deelyresearch/files/styles/profile/public/2019-05/BCPCM-portrait.png?itok=nEtgTObd)
Alejandra Raudales
Research Assistant II
Students/Trainees
![](/dept/drc/sites/deelyresearch/files/styles/profile/public/2021-02/headshot_gc_2019.jpeg?itok=hsRlajAq)
Gillian Carleton
Graduate Student
![](/dept/drc/sites/deelyresearch/files/styles/profile/public/2022-09/KDias_2022.jpg?itok=1wD5Jz54)
Kesia Dias, BSc
Graduate Student
![](/dept/drc/sites/deelyresearch/files/styles/profile/public/2023-03/JessicaMorgan_profile%20%282%29.jpg?itok=BQeWy5a8)
Jessica Morgan, BSc
Graduate Student
![](/dept/drc/sites/deelyresearch/files/styles/profile/public/2021-03/Tian.jpg?itok=SL6BcWuc)
Tian Zhao, MSc
PhD Student
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.